11th Annual Focus on Neuroendocrine Tumors, Patient and Caregiver Conference

March 11, 2022
Event Details:

Hear the latest in the treatment of GI, lung, and pheo-para NETs

Could I feel better? If you’ve been diagnosed with a neuroendocrine tumor (NET) and have asked yourself this question, please join us for a very special program. On March 11, Penn Medicine will bring together more than 30 experts in neuro-endocrine tumors to share updates and answer your questions.

Afternoon breakout sessions will offer attendees the opportunity to be in a virtual room with a multidisciplinary team of doctors and nurses who treat either GEP NETs (GI), lung carcinoids, or pheochromocytomas and paragangliomas (Pheo-Para) NETs. Bring your questions or just plan to listen.

The meeting will also feature practical and scientific talks on key topics. This annual event is intended for people who are newly diagnosed with NETs, currently in treatment, or long-term survivors. Caregivers and family members are welcome as well.

Keynote Address: "Nuclear Medicine 101 for NETs" by Daniel A. Pryma, MD, chief of Nuclear Medicine at the University of Pennsylvania.

Who Should Attend

Newly diagnosed, currently in treatment or long-term survivor of:

  • Gastrointestinal Tract NETs including: Pancreatic NET (hereditary or sporadic)
  • Zollinger-Ellison syndrome (gastrinomas)
  • Insulinomas
  • Alimentary tract NETs (foregut, midgut or hindgut)
  • Functional (carcinoid syndrome)
  • Non-functional
  • Bronchial, Thymic and Carcinoid in other locations
  • Pheochromocytomas and Paragangliomas including hereditary and sporadic forms
  • Hereditary Syndromes associated with Neuroendocrine Tumors